PULSE: A Randomized, Phase II Open Label Study of PanitUmumab RechaLlenge Versus Standard Therapy after Progression on Anti-EGFR Therapy in Patients with Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Clinical Trial Grant

Duke Scholars

Principal Investigator John Strickler Medicine, Medical Oncology

Awarded By

Academic and Community Cancer Research United

Start Date

January 2, 2020

End Date

January 2, 2025

Awarded By

Academic and Community Cancer Research United

Start Date

January 2, 2020

End Date

January 2, 2025